Zhang, Panpan <br/><br/>
Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.  [electronic resource] 

 -  International journal of rheumatic diseases  Aug 2019 
 - 1479-1488 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1756-185X 
<br/><br/><label>Standard No.: </label>10.1111/1756-185X.13633  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--adverse effects<br/>Adult<br/>Autoimmunity--drug effects<br/>Betamethasone--analogs & derivatives<br/>Biomarkers--blood<br/>China<br/>Chromones--adverse effects<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Immunoglobulin G4-Related Disease--blood<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Metabolome<br/>Middle Aged<br/>Prospective Studies<br/>Remission Induction<br/>Severity of Illness Index<br/>Sulfonamides--adverse effects<br/>Time Factors<br/>Treatment Outcome